Rozanolixizumab in generalized myasthenia gravis: Pooled analysis of the Phase 3 MycarinG study and two open-label extensions
J Neuromuscul Dis. 2025 Mar 4:22143602241305511. doi: 10.1177/22143602241305511. Online ahead of print. ABSTRACT BACKGROUND: Myasthenia gravis (MG) is a chronic autoimmune disease causing fluctuating muscle …